Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Impact on Coronary Lipid Pool
NCT02282332Phase 4Completed
- Sponsor
- MedStar Health Research Institute
- Start
- Jun 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of ticagrelor in coronary artery disease (CAD), sponsored by MedStar Health Research Institute. Primary endpoint: Change From Baseline Lipid Pool to Follow up as Assessed by NIRS/IVUS at 6 months. Started Jun 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02282332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282332.